3 Growth Stocks to Own in 2018
With U.S. stocks at all-times highs, it can be a serious challenge to find growth vehicles that are still worth buying at these levels. To do so, I think investors may want to try to mine the depths of the small-cap biotechnology space to unearth compelling bargains. Some of these stocks, after all, are nearing pivotal catalysts that could drive their shares much higher next year and beyond.
Keeping with this theme, I'm personally considering adding Amarin (NASDAQ: AMRN), Novavax (NASDAQ: NVAX), and Dynavax Technologies Corporation (NASDAQ: DVAX) to my portfolio early next year. Here's why.
Image source: Getty Images.
Source: Fool.com
Dynavax Technologies Corp Stock
€9.98
-1.010%
Currently there is a rather positive sentiment for Dynavax Technologies Corp with 3 Buy predictions and 0 Sell predictions.
With a target price of 27 € there is potential for a 170.49% increase which would mean more than doubling the current price of 9.98 € for Dynavax Technologies Corp.
